1. Chitosan nanocarrier for FTY720 enhanced delivery retards Parkinson’s disease via PP2A-EzH2 signaling in vitro and ex vivo
   Mohammed Nadim Sardoiwala et al, 2021, Carbohydrate Polymers CrossRef
2. Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis
   Amritha A. Candadai et al, 2021, Cells CrossRef
3. FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation
   Shu Yao et al, 2019, Journal of Neuroimmune Pharmacology CrossRef
4. Sphingosine 1-Phosphate Receptor-1 Enhances Mitochondrial Function and Reduces Cisplatin-Induced Tubule Injury
   Amandeep Bajwa et al, 2015, Journal of the American Society of Nephrology CrossRef
5. Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
   Joanna A. Motyl et al, 2021, International Journal of Molecular Sciences CrossRef
6. Celastrol ameliorates Cd‐induced neuronal apoptosis by targeting NOX2‐derived ROS‐dependent PP5‐JNK signaling pathway
   Chong Xu et al, 2017, Journal of Neurochemistry CrossRef
7. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration
   Sofia Anastasiadou et al, 2016, Experimental Neurology CrossRef